We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
-4.17%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$68.3B
AUM Growth
-$3.23B
(-4.5%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
15.18%
Holding
779
New
72
Increased
344
Reduced
301
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$374M |
| 2 |
FirstEnergy
FE
|
+$348M |
| 3 |
Allstate
ALL
|
+$267M |
| 4 |
Sanofi
SNY
|
+$259M |
| 5 |
JPMorgan Chase
JPM
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$603M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$561M |
| 3 |
Novartis
NVS
|
+$233M |
| 4 |
KLA
KLAC
|
+$233M |
| 5 |
UnitedHealth
UNH
|
+$207M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.86% |
| 2 | Healthcare | 17.72% |
| 3 | Industrials | 14.6% |
| 4 | Technology | 13.23% |
| 5 | Energy | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHCR
676
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $204K | ﹤0.01% |
+107,595
| New | +$189K |
|
677
Lulu's Fashion Lounge
LVLU
$55M
| $203K | ﹤0.01% |
2,908
+1,299
| +81% | +$142K |
|
678
The RealReal
REAL
$1.34B
| $202K | ﹤0.01% |
134,784
+28,880
| +27% | +$69.8K |
|
679
Star Bulk Carriers
SBLK
$3.14B
| $190K | ﹤0.01% |
+10,841
| New | +$247K |
|
680
CareDx
CDNA
$1.92B
| $174K | ﹤0.01% |
10,194
-273
| -3% | -$5.86K |
|
681
Dana Inc
DAN
$2.91B
| $174K | ﹤0.01% |
15,247
-94,473
| -86% | -$1.43M |
|
|
EEX
682
DELISTED
Emerald Holding
EEX
| $169K | ﹤0.01% |
49,854
+9,975
| +25% | +$36K |
|
683
Mammoth Energy Services
TUSK
$132M
| $154K | ﹤0.01% |
45,073
-27,079
| -38% | -$94.4K |
|
|
SCTL
684
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $150K | ﹤0.01% |
92,246
-106,466
| -54% | -$124K |
|
685
Alibaba
BABA
$269B
| $146K | ﹤0.01% |
26,479
+9,412
| +55% | +$897K |
|
686
Ovid Therapeutics
OVID
$435M
| $142K | ﹤0.01% |
77,003
+847
| +1% | +$1.77K |
|
|
AUGX
687
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $141K | ﹤0.01% |
97,516
+1,073
| +1% | +$1.84K |
|
688
Talkspace
TALK
$873M
| $140K | ﹤0.01% |
136,214
+1,498
| +1% | +$2.2K |
|
689
Coty
COTY
$2.33B
| $130K | ﹤0.01% |
+369,011
| New | +$2.79M |
|
690
Mistras Group
MG
$492M
| $127K | ﹤0.01% |
28,570
+314
| +1% | +$1.78K |
|
691
Itaú Unibanco
ITUB
$91.3B
| $126K | ﹤0.01% |
463,649
+2,007
| +0.4% | +$8.56K |
|
692
Verastem
VSTM
$532M
| $126K | ﹤0.01% |
12,361
+4,079
| +49% | +$56.9K |
|
693
GDS Holdings
GDS
$6.34B
| $121K | ﹤0.01% |
+30,339
| New | +$796K |
|
694
Kanzhun
BZ
$6.89B
| $120K | ﹤0.01% |
+28,297
| New | +$639K |
|
695
Wayfair
W
$11.1B
| $116K | ﹤0.01% |
+23,167
| New | +$1.22M |
|
|
MRC
696
DELISTED
MRC Global
MRC
| $111K | ﹤0.01% |
15,386
+169
| +1% | +$1.67K |
|
|
GPGI
697
GPGI Inc
GPGI
$4.06B
| $109K | ﹤0.01% |
26,242
+290
| +1% | +$1.36K |
|
|
OPTU
698
Optimum Communications Inc
OPTU
$316M
| $106K | ﹤0.01% |
18,242
-15,696
| -46% | -$150K |
|
699
SmartRent
SMRT
$183M
| $97K | ﹤0.01% |
42,688
+8,116
| +23% | +$32K |
|
700
Alpha and Omega Semiconductor
AOSL
$923M
| $95K | ﹤0.01% |
+35,188
| New | +$1.3M |
|
Similar funds
Boston Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Boston Partners held 779 positions worth $68.3B, down 4.5% from $71.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q3 2022 filing shows 72 new, 344 increased, 301 reduced and 59 closed positions. Its largest new stake was FirstEnergy: 8,800,892 shares worth $326M. The largest sale was Procter & Gamble, an estimated $603M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q3 2022 buy was FirstEnergy: 8,800,892 shares worth $326M.
- Boston Partners added most to Bristol-Myers Squibb in Q3 2022, an estimated $374M increase.
- Boston Partners's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $561M.
- Boston Partners fully exited Procter & Gamble in Q3 2022, selling an estimated $603M.
- Boston Partners's ten largest holdings make up 15% of its $68.3B portfolio in Q3 2022.
- Boston Partners opened 72 new positions and closed 59 in Q3 2022.
- Boston Partners's portfolio value fell 4.5% quarter-over-quarter to $68.3B.
Based on Boston Partners's 13F filing for Q3 2022, filed 9 Nov 2022.